HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 27, 2026

HTG Molecular Diagnostics Revenue

HTG Molecular Diagnostics had revenue of $1.03M in the quarter ending March 31, 2023, a decrease of -12.83%. This brings the company's revenue in the last twelve months to $6.21M, down -28.21% year-over-year. In the year 2022, HTG Molecular Diagnostics had annual revenue of $6.37M, down -28.52%.

Revenue (ttm)
6.21M
Revenue Growth
-28.21%
P/S Ratio
0.00
Revenue / Employee
115.08K
Employees
54
Market Cap
221.00

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20226.37M-2.54M-28.52%
Dec 31, 20218.91M357.96K4.19%
Dec 31, 20208.55M-10.66M-55.48%
Dec 31, 201919.20M-2.30M-10.70%
Dec 31, 201821.50M6.74M45.69%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Response Genetics16.62M
Todos Medical10.75M
RushNet6.90M
Rosetta Genomics2.86M
Arrayit2.82M
Biocept1.36M
Optigenex991.25K
Medivolve666.14K
Revenue Rankings